You are here

U.S. agency offers legal immunity to Ebola vaccine makers

Primary tabs

REUTERS                                                                                                                    Dec. 9, 2014

CHICAGO -- The U.S. Department of Health and Human Services on Tuesday offered liability protections to drugmakers rushing to develop Ebola vaccines and urged other countries to follow suit.

Health and Human Services (HHS) Secretary Sylvia Burwell made the announcement as part of the Public Readiness and Emergency Preparedness (PREP) Act in a move aimed at encouraging the development and availability of experimental Ebola vaccines.

The declaration provides immunity under U.S. law against legal claims related to the manufacturing, testing, development, distribution, and administration of three vaccines for the Ebola virus. However, it does not provide immunity for a claim brought in a court outside the United States...

Read full story

http://www.reuters.com/article/2014/12/09/us-health-ebola-vaccine-idUSKBN0JN1S920141209

Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -

Comments

XCONOMY       by Frank Vinlua                                                                                       Dec. 9, 2014

Ebola research has yet to yield a proven vaccine or antiviral drug but the work done so far could be paving the way for something else—faster and more efficient ways of testing drug candidates for other diseases.

Jeffrey Spaeder, chief medical officer for Durham, NC, contract research organization Quintiles (NYSE: Q), says the current Ebola outbreak has placed urgency on a drug development process that typically requires years of testing to determine safety and efficacy. But he says urgency also leads life science companies, non-profit organizations, and government bodies to work together in new ways.

http://www.xconomy.com/raleigh-durham/2014/12/09/how-ebola-drug-trials-today-could-shape-future-drug-development/

howdy folks
Page loaded in 0.553 seconds.